New research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers
Third Cytiva FlexFactory manufacturing platform will help the CDMO meet the rising demand for genomic medicines
Expert video interviews on the latest technological innovations for clinical labs
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples
Minimizes common user errors by up to 40% and enhances audit readiness by providing end-to-end traceability and data integrity
Additions to company’s range of bioanalytical antibodies and reagents enhances bioanalysis and antibody-related research
QuickMIC systems have already been installed at both hospitals and are now in the process of being implemented in clinical routine
